1. The annual fees cover a portion of costs related to TPP's medical device product post-market monitoring activities.

2. Currently, additional working groups of CAs, chaired by the Commission, have been established to address specific issues such as herbicide resistance, Bt toxin, antibiotic resistance marker genes, post-market monitoring and ease of access to and exchange of information.